187 filings
15F-12B
PHXM
PHAXIAM Therapeutics S.A.
11 Mar 24
Securities registration termination (foreign)
8:31am
EFFECT
PHXM
PHAXIAM Therapeutics S.A.
6 Mar 24
Notice of effectiveness
12:15am
S-8 POS
PHXM
PHAXIAM Therapeutics S.A.
4 Mar 24
Registration of securities for employees (post-effective amendment)
4:28pm
S-8 POS
PHXM
PHAXIAM Therapeutics S.A.
4 Mar 24
Registration of securities for employees (post-effective amendment)
4:27pm
S-8 POS
PHXM
PHAXIAM Therapeutics S.A.
4 Mar 24
Registration of securities for employees (post-effective amendment)
4:25pm
S-8 POS
PHXM
PHAXIAM Therapeutics S.A.
4 Mar 24
Registration of securities for employees (post-effective amendment)
4:22pm
S-8 POS
PHXM
PHAXIAM Therapeutics S.A.
4 Mar 24
Registration of securities for employees (post-effective amendment)
4:14pm
POS AM
PHXM
PHAXIAM Therapeutics S.A.
4 Mar 24
Prospectus update (post-effective amendment)
4:09pm
25
PHXM
PHAXIAM Therapeutics S.A.
1 Mar 24
Voluntary exchange delisting
4:04pm
6-K
PHXM
PHAXIAM Therapeutics S.A.
21 Feb 24
PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market
6:05am
6-K
PHXM
PHAXIAM Therapeutics S.A.
19 Jan 24
PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024
10:04am
6-K
PHXM
PHAXIAM Therapeutics S.A.
16 Nov 23
PHAXIAM Provides Business and Financial Update
7:41am
6-K
PHXM
PHAXIAM Therapeutics S.A.
25 Oct 23
Current report (foreign)
9:21am
6-K
PHXM
PHAXIAM Therapeutics S.A.
11 Oct 23
PHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phages over clinical strains
6:53am
6-K
PHXM
PHAXIAM Therapeutics S.A.
5 Oct 23
PHAXIAM Therapeutics and Vetophage Announce
7:32am
6-K
PHXM
PHAXIAM Therapeutics S.A.
26 Sep 23
I.Certification of the Person Responsible for the Half-year Financial Report
3:01pm
6-K
PHXM
PHAXIAM Therapeutics S.A.
21 Sep 23
Current report (foreign)
8:42am
6-K
PHXM
PHAXIAM Therapeutics S.A.
18 Sep 23
PHAXIAM Therapeutics announces the completion of its reverse share split
8:16am
6-K
PHXM
PHAXIAM Therapeutics S.A.
15 Sep 23
Current report (foreign)
8:03am
6-K
PHXM
PHAXIAM Therapeutics S.A.
7 Sep 23
PHAXIAM Therapeutics publishes its cash position and new financial calendar, and announces its participation at upcoming investor conferences
9:33am